Vericel Corporation (VCEL): Price and Financial Metrics


Vericel Corporation (VCEL)

Today's Latest Price: $20.20 USD

0.60 (3.06%)

Updated Oct 22 4:00pm

Add VCEL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

VCEL Stock Summary

  • VCEL's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 295,568.8 -- higher than 100% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for Vericel Corp is higher than 95.04% of stocks in our set with a positive cash flow.
  • VCEL's price/sales ratio is 7.61; that's higher than the P/S ratio of 82.75% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Vericel Corp are AC, ZEN, GHM, PDFS, and PRSC.
  • Visit VCEL's SEC page to see the company's official filings. To visit the company's web site, go to vcel.com.

VCEL Stock Price Chart Interactive Chart >

Price chart for VCEL

VCEL Price/Volume Stats

Current price $20.20 52-week high $22.26
Prev. close $19.60 52-week low $6.78
Day low $19.07 Volume 455,700
Day high $20.27 Avg. volume 650,358
50-day MA $18.22 Dividend yield N/A
200-day MA $15.43 Market Cap 914.05M

Vericel Corporation (VCEL) Company Bio


Vericel Corporation focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company was founded in 1989 and is based in Cambridge, Massachusetts.


VCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

VCEL Latest Social Stream


Loading social stream, please wait...

View Full VCEL Social Stream

Latest VCEL News From Around the Web

Below are the latest news stories about Vericel Corp that investors may wish to consider to help them evaluate VCEL as an investment opportunity.

Vericel (VCEL) Investor Presentation - Slideshow

The following slide deck was published by Vericel Corporation in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

MediWound: An Underfollowed Opportunity At A Discount

MediWound (MDWD) has popped up on my scanner several times over the past couple of years following some potent company press releases and catalysts. Admittedly, I would take a look at the headline and then check the ticker only to see a big move followed by a fade, so I...

Biologics on Seeking Alpha | September 8, 2020

World Cell & Gene Therapy Markets, 2025 - Leading Players are Gilead Sciences, Spark Therapeutics, Novartis, Organogenesis, Amgen, Osiris Therapeutics, Dendreon, and Vericel - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included The study considers the present scenario of the cell and gene therapy market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and suppl

Business Wire | August 6, 2020

Vericel (VCEL) Q2 2020 Earnings Call Transcript | The Motley Fool

VCEL earnings call for the period ending June 30, 2020.

The Motley Fool | August 6, 2020

Vericel Reports Second Quarter 2020 Financial Results

Product Revenues of $20.0 Million Reported for the Second Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE…

GlobeNewswire | August 5, 2020

Read More 'VCEL' Stories Here

VCEL Price Returns

1-mo 11.66%
3-mo 28.50%
6-mo 49.63%
1-year 26.49%
3-year 369.77%
5-year 852.83%
YTD 16.09%
2019 0.00%
2018 219.27%
2017 81.67%
2016 16.28%
2015 -15.13%

Continue Researching VCEL

Here are a few links from around the web to help you further your research on Vericel Corp's stock as an investment opportunity:

Vericel Corp (VCEL) Stock Price | Nasdaq
Vericel Corp (VCEL) Stock Quote, History and News - Yahoo Finance
Vericel Corp (VCEL) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8153 seconds.